Skip to main content

Advertisement

Log in

Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Objective

This work investigated the profile of inflammation biomarkers in patients with chronic hepatitis C and its association with liver fibrosis, hepatic necroinflammatory activity, viral genotypes and cryoglobulinemia.

Subjects and methods

Seventy-eight untreated patients were studied. Biomarker levels were determined by immunoassays, cryoglobulinemia by cryoprecipitation and liver histopathology investigated using METAVIR scores.

Results

Decreased levels of α1-acid glycoprotein (AGP), C3 and haptoglobin (Hp) were observed in the patients (P < 0.0001). Increased α1-antitrypsin (P < 0.01) and ferritin (P < 0.0001) levels were found in this group, but C-reactive protein (CRP) and C4 levels were unaltered. Alanine aminotransferase inversely correlated with Hp (P < 0.01) and AGP (P = 0.01), whereas it was directly correlated with ferritin (P < 0.05) and AGP (P < 0.0001). The levels of CRP, C3 and C4 were lower in the patients with hepatic necroinflammatory activity (P < 0.05). Patients with advanced fibrosis had low levels of Hp and AGP (P < 0.05 and P < 0.01, respectively). Neither infection with different viral genotypes nor cryoglobulinemia caused an alteration in biomarker levels.

Conclusion

Chronic hepatitis C virus infection alters the levels of some biomarkers, which are mainly observed in patients with liver fibrosis and hepatic necroinflammatory activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Tellinghuisen T, Rice C. Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol. 2002;5:419–27.

    Article  PubMed  CAS  Google Scholar 

  2. Chen S, Morgan T. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3:47–52.

    Article  PubMed  Google Scholar 

  3. Dustin L, Rice C. Flying under the radar: the immunobiology of hepatitis C. Ann Rev Immunol. 2007;25:71–99.

    Article  CAS  Google Scholar 

  4. Atta AM, Estevam P, Paraná R, Pereira CM, Leite BC, Sousa-Atta ML. Antiphospholipid antibodies in Brazilian hepatitis C virus carriers. Braz J Med Biol Res. 2008;41:489–92.

    Article  PubMed  CAS  Google Scholar 

  5. Atta AM, Oliveira IS, Sousa GM, Paraná R, Sousa Atta ML. Serum cytokine profile in hepatitis C virus carriers presenting cryoglobulinaemia and non-organ-specific autoantibodies. Microb Pathogen. 2010;48:53–6.

    Article  CAS  Google Scholar 

  6. Gramenzi A, Andreone P, Loggi E, Foschi F, Cursaro C, Margotti M, et al. Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. J Viral Hepat. 2005;12:525–30.

    Article  PubMed  CAS  Google Scholar 

  7. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–54.

    Article  PubMed  CAS  Google Scholar 

  8. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology. 1996;24:289–93.

    Article  PubMed  CAS  Google Scholar 

  9. Poynard T, Imbert-Bismut F, Ratziu V, Chevret S, Jardel C, Moussalli J, et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat. 2002;9:128–33.

    Article  PubMed  CAS  Google Scholar 

  10. Rosenthal-Allieri M, Peritore M-L, Tran A, Halfon P, Benzaken S, Bernard A. Analytical variability of the Fibrotest proteins. Clin Biochem. 2005;38:473–8.

    Article  PubMed  CAS  Google Scholar 

  11. Bacq Y, Schillio Y, Brechot J, De Muret A, Dubois F, Metman E. Decrease of haptoglobin serum level in patients with chronic viral hepatitis C. Gastroenterol Clin Biol. 1993;17:364–9.

    PubMed  CAS  Google Scholar 

  12. Kasvosve I, Gomo Z, Gangaidzo I, Mvundura E, Saungweme T, Moyo V, et al. Reference range of serum haptoglobin is phenotype-dependent in blacks. Clin Chim Acta. 2000;296:163–70.

    Article  PubMed  CAS  Google Scholar 

  13. Hochepied T, Berger FG, Baumann H, Libert C. Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev. 2003;14:25–34.

    Article  PubMed  CAS  Google Scholar 

  14. Fournier T, Medjoubi-N N, Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta. 2000;1482:157–71.

    Article  PubMed  CAS  Google Scholar 

  15. Anderson N, Pollacchi A, Hayes P, Therapondos G, Newsome P, Boyter A, Smith K. A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseases. Biomed Chromatogr. 2002;16:365–72.

    Article  PubMed  CAS  Google Scholar 

  16. Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H, Vogel W. High prevalence of viral infection in adults with homozygous and heterozygous alpha 1-antitrypsin and chronic liver disease. Ann Intern Med. 1992;117:641–5.

    PubMed  CAS  Google Scholar 

  17. Elzouki AN, Verbaan H, Lindgren S, Widell A, Carlson J, Eriksson S. Serine protease inhibitors in patients with chronic viral hepatitis. J Hepatol. 1997;27:42–8.

    Article  PubMed  CAS  Google Scholar 

  18. Lin T, Liao L, Lin S, Lin C, Chang T. Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C. World J Gastroenterol. 2006;12:4897–901.

    PubMed  CAS  Google Scholar 

  19. Fabris C, Toniutto P, Scott C, Falleti E, Avellini C, Del Forno M, et al. Serum iron indices as a measure of iron deposits in chronic hepatitis C. Clin Chim Acta. 2001;304:49–55.

    Article  PubMed  CAS  Google Scholar 

  20. Metwally M, Zein C, Zein N. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol. 2004;99:286–91.

    Article  PubMed  CAS  Google Scholar 

  21. Guyader D, Thirouard A, Erdtmann L, Rakba N, Jacquelinet S, Danielou H, et al. Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C. J Hepatol. 2007;46:587–95.

    Article  PubMed  CAS  Google Scholar 

  22. Shan Y, Lambrecht RW, Bonkovsky HL. Association of hepatitis C virus infection with serum iron status: analysis of data from the third national health and nutrition examination survey. Clin Infect Dis. 2005;40:834–41.

    Article  PubMed  CAS  Google Scholar 

  23. Sousa GM, Oliveira RC, Pereira MM, Paraná R, Sousa-Atta MLB, Atta AM. Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin. Autoimmun Rev. 2011;10:210–3.

    Article  PubMed  CAS  Google Scholar 

  24. Distante S, Bjoro K, Hellum K, Myrvang B, Berg J, Skaug K, et al. Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection. Liver. 2002;22:269–75.

    Article  PubMed  CAS  Google Scholar 

  25. Kalabay L, Nemesánszky E, Csepregi A, Pusztay M, Dávid K, Horváth G, et al. Paradoxical alteration of acute-phase protein levels in patients with chronic hepatitis C treated with IFN-alpha2b. Int Immunol. 2004;16:51–4.

    Article  PubMed  CAS  Google Scholar 

  26. Nascimento M, Bruchfeld A, Suliman M, Hayashi S, Pecoits-Filho R, Manfro R, et al. Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients. Braz J Med Biol Res. 2005;38:783–8.

    Article  PubMed  CAS  Google Scholar 

  27. Kessel A, Elias G, Pavlotzky E, Zuckerman E, Rosner I, Toubi E. Anti-C-reactive protein antibodies in chronic hepatitis C infection: correlation with severity and autoimmunity. Hum Immunol. 2007;68:844–8.

    Article  PubMed  CAS  Google Scholar 

  28. Mazumdar B, Kim H, Meyer K, Bose SK, Di Bisceglie AM, Ray RB. Hepatitis C virus proteins inhibit C3 complement production. J Virol. 2012;86:2221–8.

    Article  PubMed  CAS  Google Scholar 

  29. Dumestre-Perard C, Ponard D, Drouet C, Leroy V, Zarski J-P, Dutertre N, Colomb MG. Complement C4 monitoring in the follow-up of chronic hepatitis C treatment. Clin Exp Immunol. 2002;127:131–6.

    Article  PubMed  CAS  Google Scholar 

  30. Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis. 2005;5:227–36.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Maria L.B. Sousa Atta, Ajax M. Atta and R. Paraná have fellowships for Research Productivity from the Brazilian National Council for Scientific and Technological Development (CNPq). The research was supported by CNPq (No.486187/2006-3).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Atta.

Additional information

Responsible Editor: Kumar Visvanathan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atta, M., Cabral, M., Santos, G. et al. Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia. Inflamm. Res. 61, 1101–1106 (2012). https://doi.org/10.1007/s00011-012-0502-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-012-0502-2

Keywords

Navigation